Trosunilimab

N/A

Report date: 2026/02/13 20:01:31

Base Information

Drug NameTrosunilimab
Drug Alias NameABBV-382
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionIntegrin alpha-4/beta-7 antagonists
TargetsIntegrin alpha-4/beta-7
Therapy Area/IndicationsCrohn DiseaseHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[37] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbbvie LtdAbbvie IncAbbvie Pharmaceutical Trading（Shanghai）Co Ltd
Inactive CompaniesN/A
Active IndicationsCrohn DiseaseHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A